Inhibition of Human Immunodeficiency Virus Type 1-mediated Cytopathic Effects by Poly(l-lysine)-conjugated Synthetic Antisense Oligodeoxyribonucleotides

References

1. Agris C. H., Blake K. R., Miller P. S., Reddy M. P., Ts’o P. O. P. 1986; Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates. Biochemistry 25:6268–6275
   [Google Scholar]
2. Barré-Sinoussi F., Cherman J. C., Rey R., Nugeyere M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Brun-Vexinet F., Rouzioux C., Rozenbaum W., Montagnier L. 1983; Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 220:868–871
   [Google Scholar]
3. Casareale D., Dewhurst S., Sonnabend J., Sinangil F., Purtilo D., Volsky D. J. 1985; Prevalence of AIDS-associated retrovirus and anti-bodies among male homosexuals at risk for AIDS in Greenwich Village. AIDS Research 1:407–421
   [Google Scholar]
4. Casareale D., Stevenson M., Sakai K., Volsky D. 1987; A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV-1). Virology 156:40–49
   [Google Scholar]
5. Chirgwin J. M., Pryzbyla A. E., Mcdonald R., Rutter W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
   [Google Scholar]
6. Coleman J., Hirashima A., Inokuchi Y., Green P. J., Inouye M. 1985; A novel immune system against bacteriophage infection using complementary RNA (mic RNA). Nature London: 315601–603
   [Google Scholar]
7. Dalgleish A. G., Beverley P. C. L., Clapham P. R., Crawford D. R., Greaves M. F., Weiss R. A. 1984; The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature London: 312763–767
   [Google Scholar]
8. Gunning P., Ponte P., Okayama H., Engel J., Blau H., Keddes L. 1983; Isolation and characterization of full-length cDNA clones for human α, β, and γ-actin mRNAs: skeletal but not cytoplasmic actins have an aminoterminal cysteine that is subsequently removed. Molecular and Cellular Biology 3:787–795
   [Google Scholar]
9. Hall J. L., Dudley L., Dobner P., Lewis S. A., Cowan N. J. 1983; Identification of two human β-tubulin isotypes. Molecular and Cellular Biology 3:854–862
   [Google Scholar]
10. Harada S., Koyonagi Y., Yamamoto N. 1985; Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563–566
    [Google Scholar]
11. Harada S., Koyanagi Y., Nakashima H., Kobayashi N., Yamamoto N. 1986; Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology 154:249–258
    [Google Scholar]
12. Hoxie I. A., Alpers J. D., Rackowski J. L., Huebner K., Haggarty B. S., Cedarbaum A. J., Reed J. D. 1986; Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV-1. Science 234:1123–1127
    [Google Scholar]
13. Izant J. G., Weintraub H. 1984; Inhibition of thymidine kinase gene expression by antisense RNA: a molecular approach to genetic analysis. Cell 36:1007–1015
    [Google Scholar]
14. Izant J. G., Weintraub H. 1985; Constitutive and conditional suppression of exogenous and endogenous genes by antisense RNA. Science 229:345–352
    [Google Scholar]
15. Kaufman J. D., Valandra G., Roderiquez G., Bushar G., Giri C., Norcross A. 1987; Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base pair functional enhancer element. Molecular and Cellular Biology 7:3759–3766
    [Google Scholar]
16. Kim S. K., Wold B. J. 1985; Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA. Cell 42:129–138
    [Google Scholar]
17. Lemaitre M., Bayard B., Lebleu B. 1987; Specific antiviral activity of a poly(l-lysine)-conjugated oligo-deoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proceedings of the National Academy of SciencesU.S.A 84648–652
    [Google Scholar]
18. Levy J. A., Hoffman A. D., Kramer S. M., Landis J. A., Shimabukuro J. M., Oskiro L. S. 1984; Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840–842
    [Google Scholar]
19. Lifson J. D., Feinberg M. B., Reyes G. R., Rabin L., Banapour B., Chakrabarti S., Moss B., Wong-STAAL F., Steimer K. S., Engleman E. G. 1986; Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature London: 323725–728
    [Google Scholar]
20. Lifson J. D., Reyes G. R., Mcgrath M. S., Stein B. J., Engleman E. G. 1986b; AIDS retrovirus induced cytopathology: giant cell formation and involvement of the CD4 antigen. Science 232:1123–1127
    [Google Scholar]
21. Lindell T. J., Weinberg F., Morris P. W., Roeder R. G., Rutter W. J. 1970; Specific inhibition of nuclear RNA polymerase II by α-amanitin. Science 170:447–449
    [Google Scholar]
22. Maddon P. J., Dalgleish A. G., Mcdougal I. S., Clapham P. R., Weiss R. A., Axel R. 1986; The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–348
    [Google Scholar]
23. Miyoshi I., Taguchi H., Kubonishi I., Yoshimoto S., Ohrauki Y., Shiraishi Y., Akagi T. 1982; Type-C virus producing cell lines derived from adult T-cell leukemia. Japanese Journal of Cancer Research 28:219–228
    [Google Scholar]
24. Murakami A., Blake K. R., Miller P. S. 1985; Characterization of sequence-specific oligodeoxyribonucleotide methylphosphonates and their interaction with rabbit globin mRNA. Biochemistry 24:4041–4046
    [Google Scholar]
25. Pellegrino M. G., Lewin M., Meyer W. A., Lanciotti R. S., Bhaduri-HAUCK L., Volsky D. I., Sakai K., Folks T. M., Gillespie D. 1987; A sensitive solution hybridization technique for detecting RNA in cells: application to HIV-1 in blood cells. Biotechniques 5:452–159
    [Google Scholar]
26. Rhode S. L., Paradiso P. R. 1983; Parvovirus genome: nucleotide sequence of HI and mapping of its genes by hybrid arrested translation. Journal of Virology 45:173–184
    [Google Scholar]
27. Schott M. E. 1985; A simple manual method for oligonucleotide synthesis. American Synthesis Biotechnology Laboratory Jan/Feb
    [Google Scholar]
28. Smith C. C., Aurelian L., Reddy M. P., Miller P. S., Ts’o P. O. P. 1986; Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type I immediate early pre-mRNAs 4 and 5. Proceedings of the National Academy of SciencesU.S.A 832787–2791
    [Google Scholar]
29. Stevenson M., Meier C., Mann A. M., Chapman N., Wasiak A. 1988; Envelope glycoprotein of HIV-1 induces interference and cytolysis resistance in CD4⁺ cells: mechanism for persistence in AIDS. Cell 53:483–496
    [Google Scholar]
30. Wain-Hobson S., Sonigo P., Danos O., Cole S., Alizon M. 1985; Nucleotide sequence of the AIDS virus, LAV. Cell 40:9–17
    [Google Scholar]
31. Zagury D., Bernard J., Leonard R., Cheynier R., Feldman M., Sarin P. S., Gallo R. C. 1986; Long-term cultures of HTLV-III-infected T-cells: a model of cytopathology of T-cell depletion in AIDS. Science 231:850–853
    [Google Scholar]
32. Zamecnik P. C., Goodchild J., Taguchi Y., Sarin P. S. 1986; Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proceedings of the National Academy of SciencesU.S.A 834143–4146
    [Google Scholar]